A FLUORINE-CONTAINING ANTHRACYCLINE (ME2303) AS A NEW ANTITUMOR AGENT AGAINST MURINE AND HUMAN-TUMORS AND THEIR MULTIDRUG-RESISTANT SUBLINES

被引：0
|
作者：
TSURUO, T
YUSA, K
SUDO, Y
TAKAMORI, R
SUGIMOTO, Y
机构：
来源：
CANCER RESEARCH | 1989年 / 49卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5537 / 5542
页数：6
相关论文
共 10 条
  • [1] ANTITUMOR-ACTIVITY OF ME2303, A FLUORINE-CONTAINING ANTHRACYCLINE, AGAINST HUMAN-TUMORS IMPLANTED IN NUDE-MICE
    TSURUO, T
    SATO, S
    YUSA, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (07): : 686 - 689
  • [2] ANTITUMOR-ACTIVITY AND METABOLISM OF A NEW ANTHRACYCLINE-CONTAINING FLUORINE (ME2303) IN LEWIS LUNG CARCINOMA-BEARING MICE
    IIGO, M
    HOSHI, A
    KADOSAWA, H
    FUJIGAKI, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (11): : 1317 - 1321
  • [3] MX2, A MORPHOLINO ANTHRACYCLINE, AS A NEW ANTITUMOR AGENT AGAINST DRUG-SENSITIVE AND MULTIDRUG-RESISTANT HUMAN AND MURINE TUMOR-CELLS
    WATANABE, M
    KOMESHIMA, N
    NAKAJIMA, S
    TSURUO, T
    CANCER RESEARCH, 1988, 48 (23) : 6653 - 6657
  • [4] RHIZOXIN, A MACROCYCLIC LACTONE ANTIBIOTIC, AS A NEW ANTITUMOR AGENT AGAINST HUMAN AND MURINE TUMOR-CELLS AND THEIR VINCRISTINE-RESISTANT SUBLINES
    TSURUO, T
    OHHARA, T
    IIDA, H
    TSUKAGOSHI, S
    SATO, Z
    MATSUDA, I
    IWASAKI, S
    OKUDA, S
    SHIMIZU, F
    SASAGAWA, K
    FUKAMI, M
    FUKUDA, K
    ARAKAWA, M
    CANCER RESEARCH, 1986, 46 (01) : 381 - 385
  • [5] COMPARISON OF ANTITUMOR-ACTIVITY OF NEW ANTHRACYCLINE ANALOGS, ME2303, KRN8602, AND SM5887 USING HUMAN LUNG-CANCER CELL-LINES
    TAKIGAWA, N
    OHNOSHI, T
    UEOKA, H
    KIURA, K
    KIMURA, I
    ACTA MEDICA OKAYAMA, 1992, 46 (04) : 249 - 256
  • [6] Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis
    Lee, Hye-Ra
    You, Deok-gyun
    Kim, Hong Kyu
    Sohn, Jang Wook
    Kim, Min Ja
    Park, Jong Kuk
    Lee, Gi Young
    Yoo, Young Do
    MBIO, 2020, 11 (02):
  • [7] Selective, covalent modification of β-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors
    Shan, B
    Medina, JC
    Santha, E
    Frankmoelle, WP
    Chou, TC
    Learned, RM
    Narbut, MR
    Stott, D
    Wu, PG
    Jaen, JC
    Rosen, T
    Timmermans, PBMWM
    Beckmann, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) : 5686 - 5691
  • [8] A BENZOPHENAZINE DERIVATIVE, N-BETA-DIMETHYLAMINOETHYL 9-CARBOXY-5-HYDROXY-10-METHOXY-BENZO[A]PHENAZINE-6-CARBOXAMIDE, AS A NEW ANTITUMOR AGENT AGAINST MULTIDRUG-RESISTANT AND SENSITIVE TUMORS
    TSURUO, T
    NAITO, M
    TAKAMORI, R
    TSUKAHARA, S
    YAMABEMITSUHASHI, J
    YAMAZAKI, A
    OHHARA, T
    SUDO, Y
    NAKAIKE, S
    YAMAGISHI, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (02) : 83 - 87
  • [9] The new marine derived tubulin binding agent PM060184 shows potent antitumor activity in vivo against multidrug resistant, Pgp expressing tumors.
    Aviles, Pablo M.
    Jose Guillen, Maria
    Palomares, Mandy
    Nunez, Praxedes
    Martinez-Diez, Marta
    Fernando Martinez-Leal, Juan
    Francisco Garcia-Fernandez, Luis
    Galmarini, Carlos M.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [10] POTENTIATION OF VINCRISTINE AND ACTINOMYCIN-D BY A NEW SYNTHETIC IMIDAZOLE ANTI-TUMOR AGENT YM534 ACTIVE AGAINST HUMAN CANCER-CELLS AND MULTIDRUG-RESISTANT CELLS
    SATO, S
    WATANABE, Y
    OKAMURA, K
    HAMANAKA, R
    MORI, T
    KOHNO, K
    KUWANO, M
    ANTI-CANCER DRUG DESIGN, 1989, 4 (02): : 125 - 135
1